Home / EPOP Knockout Cell Lines

EPOP Knockout Cell Lines

Gene: EPOP

Official Full Name: elongin BC and polycomb repressive complex 2 associated proteinprovided by HGNC

Gene Summary: Predicted to enable chromatin binding activity. Predicted to be involved in neuron fate commitment; regulation of transcription by RNA polymerase II; and stem cell differentiation. Predicted to be located in chromosome and nucleus. Predicted to be part of ESC/E(Z) complex and elongin complex. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO17939 EPOP Knockout cell line (HeLa) Human EPOP 1:3~1:6 Negative Online Inquiry
KO17940 EPOP Knockout cell line (HCT 116) Human EPOP 1:2~1:4 Negative Online Inquiry
KO17941 EPOP Knockout cell line (HEK293) Human EPOP 1:3~1:6 Negative Online Inquiry
KO17942 EPOP Knockout cell line (A549) Human EPOP 1:3~1:4 Negative Online Inquiry

Background

EPOP Gene Knockout Cell Lines are a pioneering class of genetically modified cell lines designed for the systematic study of gene function by facilitating the targeted disruption of specific genes. These cell lines utilize advanced CRISPR/Cas9 technology, enabling researchers to create precise, heritable mutations that allow for in-depth analysis of gene expression and protein function in a controlled environment. By knocking out the gene of interest, scientists can observe the ensuing phenotypic changes, providing critical insights into gene roles in various biological processes.

The primary function of EPOP Gene Knockout Cell Lines revolves around their ability to serve as versatile platforms for functional genomics studies. Upon gene disruption, downstream cellular pathways can be investigated, enabling nuanced exploration of disease mechanisms, drug responses, and protein interactions. This capability is particularly valuable in cancer research and therapeutic development, where understanding the contribution of specific genes to tumorigenesis or treatment resistance is crucial.

In scientific and clinical settings, these knockouts represent a significant advancement over traditional model systems, such as primary cells or standard immortalized lines, which often display heterogeneous genetic backgrounds. The controlled alteration of genes in EPOP cell lines results in consistent, reproducible data crucial for validation in translational research.

Furthermore, the unique selling points of EPOP Gene Knockout Cell Lines include their high specificity and efficiency in gene disruption, as well as a comprehensive library that covers a wide spectrum of human genes. For researchers, this means reduced experimental variability and accelerates the pace at which new findings can be translated into viable clinical applications.

Investing in EPOP Gene Knockout Cell Lines equips researchers and clinicians with the necessary tools to elucidate gene functions and contributes significantly to the fields of molecular biology and biotechnology. Our company prides itself on expertise in genetic engineering and commitment to providing high-quality biological products that empower scientific discovery and advancement.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.